...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Round one

Potentially another huge market for us:

 

Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome

 

https://www.nature.com/articles/s41467-021-27797-1

Share
New Message
Please login to post a reply